S
Sharon Gray
Researcher at Pfizer
Publications - 28
Citations - 1286
Sharon Gray is an academic researcher from Pfizer. The author has contributed to research in topics: Pneumonia & Population. The author has an hindex of 9, co-authored 20 publications receiving 367 citations.
Papers
More filters
Journal ArticleDOI
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
Sara Y. Tartof,Jeff Slezak,Heidi Fischer,Vennis Hong,Bradley Ackerson,Omesh N. Ranasinghe,Timothy B. Frankland,Oluwaseye A. Ogun,Joann M. Zamparo,Sharon Gray,Srinivas Rao Valluri,Kaije Pan,Frederick J. Angulo,Luis Jodar,John M McLaughlin +14 more
TL;DR: In this paper, the overall and variant-specific effectiveness of BNT162b2 (tozinameran, Pfizer BioNTech) against SARS-CoV-2 infections and COVID-19-related hospital admissions by time since vaccination among members of a large US health-care system was evaluated.
Journal ArticleDOI
Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
Steven Black,Daniel J. Isaacman,Laura Bracken,Edwin Lewis,John Hansen,Bruce Fireman,Robert Austrian,Jay Graepel,Sharon Gray,Nicola P. Klein +9 more
TL;DR: The incidence of invasive pneumococcal disease (IPD) in all children younger than 5 years of age in the Northern California Kaiser Permanente (NCKP) health care system during a 5-year surveillance period after the introduction in April 2000 of routine use of 7-valent pneumitis conjugate vaccine (PCV7) has significantly decreased.
Journal ArticleDOI
Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged ≥50 Years With Community-Acquired Pneumonia
Robert Sherwin,Sharon Gray,Ronika Alexander,Paul C. McGovern,Jay Graepel,Michael W. Pride,Jay Purdy,Peter Paradiso,Thomas M. File,Thomas M. File +9 more
TL;DR: Pneumococcal serotypes causing noninvasive pneumonia in adults may differ significantly from those causing invasive disease, with PCV7-associated serotypes overrepresented.
Journal ArticleDOI
Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
Juan Alberto Benavides,Oscar Omar Ovalle,Galo R. Salvador,Sharon Gray,Daniel J Isaacman,Gail L. Rodgers +5 more
TL;DR: Pneumococcal disease and pneumonia burden is considerable in children in Bogotá, Colombia and vaccination with pneumococcal conjugate vaccines has the potential to decrease this burden.
Journal ArticleDOI
Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia.
Raul E Isturiz,Julio A. Ramirez,Wesley H. Self,Carlos G. Grijalva,Francis L. Counselman,Gregory A. Volturo,Luis Ostrosky-Zeichner,Paula Peyrani,Richard G. Wunderink,Robert Sherwin,J. Scott Overcash,Senen Pena Oliva,Thomas M. File,Timothy L. Wiemken,John M McLaughlin,Michael W. Pride,Sharon Gray,Ronika Alexander,Kimbal D. Ford,Qin Jiang,Luis Jodar +20 more
TL;DR: After implementation of a pneumococcal conjugate vaccination program in US children, and despite the herd protection observed in US adults, a persistent burden of PCV13-type CAP remains in this population of adults.